
The sources said computational biologists at Reliance Life Sciences, a subsidiary of billionaire Mukesh Ambani-run Reliance Industries Ltd, analysed more than 100 genomes of SARS-CoV-2 sequenced in India and designed unique RT-PCR primers for developing quantitative-Real Time PCR (RT-PCR) kit for COVID-19 detection.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2HRsVpJ
via
IFTTT
0 comments:
Post a Comment